Gilde Healthcare portfolio company Amphista Therapeutics named as a “Fierce 15” biotech company of...
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced that Fierce Biotech has named it as one of 2022’s Fierce 15 biotechnology companies,...
gildehealthcare.com